Paul A. Friedman
Director at Madrigal Pharmaceuticals. Based in West Conshohocken, Pennsylvania.
- Rank
- 1904th of 14,644
- Companies held
- 1
- Largest holding
- MDGL, 100.0% of total
- Latest SEC filing
- Jan 9, 2026
- Listed but not counted
- $260M
What the $74.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals MDGL Common Stock | Directly | 187,164 | $396.74 | $74.3M | 100.0% | Form 4, Jan 9, 2026 |
Share counts are the amounts Paul A. Friedman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Paul A. Friedman's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals MDGL Common Stock | Through SQN LLC Held by a company or fund the insider manages | 655,540 | $396.74 | $260M | — | Form 4, Jan 9, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Sold | MDGL | 280 | $551.24 | $154K | View |
| Jan 9, 2026 | Sold | MDGL | 2,450 | $517.86 | $1.3M | View |
| Jan 9, 2026 | Sold | MDGL | 681 | $521.03 | $355K | View |
| Jan 9, 2026 | Sold | MDGL | 840 | $521.98 | $438K | View |
| Jan 9, 2026 | Sold | MDGL | 970 | $523.00 | $507K | View |
| Jan 9, 2026 | Sold | MDGL | 1,199 | $524.10 | $628K | View |
| Jan 9, 2026 | Sold | MDGL | 2,432 | $525.05 | $1.3M | View |
| Jan 9, 2026 | Sold | MDGL | 1,066 | $526.00 | $561K | View |
| Jan 9, 2026 | Sold | MDGL | 1,560 | $526.97 | $822K | View |
| Jan 9, 2026 | Sold | MDGL | 575 | $528.18 | $304K | View |
| Jan 9, 2026 | Sold | MDGL | 691 | $529.17 | $366K | View |
| Jan 9, 2026 | Sold | MDGL | 166 | $529.76 | $88K | View |
| Jan 9, 2026 | Sold | MDGL | 280 | $530.69 | $149K | View |
| Jan 9, 2026 | Sold | MDGL | 80 | $532.50 | $43K | View |
| Jan 9, 2026 | Sold | MDGL | 332 | $534.16 | $177K | View |
| Jan 9, 2026 | Sold | MDGL | 148 | $535.29 | $79K | View |
| Jan 9, 2026 | Sold | MDGL | 473 | $536.02 | $254K | View |
| Jan 9, 2026 | Sold | MDGL | 487 | $536.88 | $261K | View |
| Jan 9, 2026 | Sold | MDGL | 80 | $537.85 | $43K | View |
| Jan 9, 2026 | Sold | MDGL | 480 | $539.23 | $259K | View |
| Jan 9, 2026 | Sold | MDGL | 600 | $540.36 | $324K | View |
| Jan 9, 2026 | Sold | MDGL | 40 | $545.79 | $22K | View |
| Jan 9, 2026 | Sold | MDGL | 1,480 | $511.98 | $758K | View |
| Jan 9, 2026 | Sold | MDGL | 1,094 | $513.11 | $561K | View |
| Jan 9, 2026 | Sold | MDGL | 1,345 | $514.68 | $692K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1901 | Robert C. Pohlad Director, PepsiCo. Purchase, NY | $74.5M |
| 1902 | Oliver Pierce Smith Director, Nicolet Bankshares. Green Bay, WI | $74.4M |
| 1903 | Tali Notman CHIEF REVENUE OFFICER, JFrog. Sunnyvale, CA | $74.4M |
| 1904 | Paul A. Friedman Director, Madrigal Pharmaceuticals. West Conshohocken, PA | $74.3M |
| 1905 | Robert Enslin President, CCO, Workday. Pleasanton, CA | $74.2M |
| 1906 | C. Michael Petters Director, Huntington Ingalls Industries. Newport News, VA | $74.2M |
| 1907 | Sten Gustafson Chief Financial Officer, Pyrophyte Acquisition Corp. II. Houston, TX | $74.1M |
Other Madrigal Pharmaceuticals insiders
All MDGL insiders- Rebecca Taub$180MDirector. #965 overall
- Fred B. Craves$166MDirector. #1021 overall
- William John Sibold$78.5MPresident and CEO. #1823 overall
- Richard S. Levy$8.9MDirector. #8092 overall
- Alex G. Howarth$7.4MChief Financial Officer. #10907 overall
- Brian J. Lynch$7.2MSVP and General Counsel. #11156 overall
Questions
How much stock does Paul A. Friedman own?
Paul A. Friedman holds $74,255,445 in listed stock based on SEC filings and current prices, mostly Madrigal Pharmaceuticals (MDGL). That ranks 1904th on the Stock Rich List.
Is this Paul A. Friedman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Paul A. Friedman last buy or sell stock?
The most recent open-market trade on file is a sale of 280 MDGL shares on Jan 9, 2026 at $551.24.